Tonghua Golden-Horse Pharmaceutical Industry Co Ltd
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd., together with its subsidiaries, engages in the research, development, manufacture, and sale of pharmaceutical products in China. Its products covers anti-tumor, microbial, cardiovascular, heat-clearing and detoxification, digestive system, skeletal muscle system, gynecological system, nervous system, and other fields. The company also provides… Read more
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (000766) - Total Liabilities
Latest total liabilities as of September 2025: CN¥2.23 Billion CNY
Based on the latest financial reports, Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (000766) has total liabilities worth CN¥2.23 Billion CNY as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd - Total Liabilities Trend (1994–2024)
This chart illustrates how Tonghua Golden-Horse Pharmaceutical Industry Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd Competitors by Total Liabilities
The table below lists competitors of Tonghua Golden-Horse Pharmaceutical Industry Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Formosa Petrochemical Corp
TW:6505
|
Taiwan | NT$63.81 Billion |
|
Robert Half International Inc
NYSE:RHI
|
USA | $1.56 Billion |
|
Civitas Resources Inc
NYSE:CIVI
|
USA | $8.43 Billion |
|
Wilson Bank Holding Company
PINK:WBHC
|
USA | $5.28 Billion |
|
Shanghai Friendess Electronics Tech
SHG:688188
|
China | CN¥316.44 Million |
|
Rand Merchant Investment Holdings Limited
PINK:RMRHF
|
USA | $22.70 Billion |
|
Pampa EnergÃa S.A.
OTCGREY:PPENF
|
USA | $3.86 Trillion |
|
Sweco AB (publ)
ST:SWEC-A
|
Sweden | Skr17.47 Billion |
Liability Composition Analysis (1994–2024)
This chart breaks down Tonghua Golden-Horse Pharmaceutical Industry Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.25 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.97 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.49 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Tonghua Golden-Horse Pharmaceutical Industry Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (1994–2024)
The table below shows the annual total liabilities of Tonghua Golden-Horse Pharmaceutical Industry Co Ltd from 1994 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥2.23 Billion | +1.23% |
| 2023-12-31 | CN¥2.20 Billion | -4.99% |
| 2022-12-31 | CN¥2.32 Billion | +0.66% |
| 2021-12-31 | CN¥2.30 Billion | -13.86% |
| 2020-12-31 | CN¥2.67 Billion | +31.48% |
| 2019-12-31 | CN¥2.03 Billion | +62.65% |
| 2018-12-31 | CN¥1.25 Billion | -4.51% |
| 2017-12-31 | CN¥1.31 Billion | +14.56% |
| 2016-12-31 | CN¥1.14 Billion | -40.18% |
| 2015-12-31 | CN¥1.91 Billion | +204.96% |
| 2014-12-31 | CN¥626.09 Million | +27.28% |
| 2013-12-31 | CN¥491.91 Million | +78.69% |
| 2012-12-31 | CN¥275.29 Million | +0.95% |
| 2011-12-31 | CN¥272.69 Million | -11.09% |
| 2010-12-31 | CN¥306.71 Million | +7.48% |
| 2009-12-31 | CN¥285.36 Million | +10.81% |
| 2008-12-31 | CN¥257.51 Million | -5.51% |
| 2007-12-31 | CN¥272.53 Million | -3.38% |
| 2006-12-31 | CN¥282.05 Million | -73.43% |
| 2005-12-31 | CN¥1.06 Billion | +0.67% |
| 2004-12-31 | CN¥1.05 Billion | -7.90% |
| 2003-12-31 | CN¥1.14 Billion | +10.08% |
| 2002-12-31 | CN¥1.04 Billion | +4.62% |
| 2001-12-31 | CN¥994.08 Million | -15.82% |
| 2000-12-31 | CN¥1.18 Billion | +312.65% |
| 1999-12-31 | CN¥286.19 Million | +22.30% |
| 1998-12-31 | CN¥234.01 Million | +33.40% |
| 1997-12-31 | CN¥175.42 Million | +8.43% |
| 1996-12-31 | CN¥161.79 Million | +48.05% |
| 1995-12-31 | CN¥109.28 Million | +77.17% |
| 1994-12-31 | CN¥61.68 Million | -- |